Pakistani girl shot by Taliban leaves British hospital

Pakistani schoolgirl Malala Yousufzai waves with nurses as she is discharged from The Queen Elizabeth Hospital in Birmingham in this handout photographLONDON (Reuters) – A Pakistani girl shot in the head by the Taliban for advocating girls' education has been discharged from a British hospital after doctors said she was well enough to spend time recovering with her family. Fifteen-year-old Malala Yousufzai, who was shot by the Taliban in October and brought to Britain for treatment, was discharged on Thursday but is due to be re-admitted in late January or early February for reconstructive surgery to her skull, doctors said. …

Insight: "Fiscal cliff" fracas: From smiles to distrust to rancor

Speaker of the House John Boehner speaks to the press after a bipartisan meeting with U.S. President Barack Obama to discuss the economy in the Roosevelt Room of the White House(Note: includes graphic language) WASHINGTON (Reuters) – It began so optimistically. On November 16, after their first "fiscal cliff" session with President Barack Obama, the four leaders of Congress had stood in the driveway of the White House shoulder-to-shoulder for what is a rare photo these days, Republicans and Democrats together, smiling. There they were at the microphone, talking about a "framework" for tax reform and deficit reduction. …

UK backs Lucentis for new use after Novartis cuts price

LONDON (Reuters) – Britain’s healthcare cost watchdog has given its backing to eye drug Lucentis to treat diabetes-related problems after Swiss drugmaker Novartis offered it at a discount to the National Health Service. The National Institute for Health and Clinical Excellence (NICE), in a reversal of an earlier decision, said on Friday Lucentis should now be available for patients with diabetic macular oedema (DMO). Lucentis is already approved by NICE to treat wet age-related macular degeneration. …

Analysis: Alimta patent seen as Lilly’s "wild card"

NEW YORK (Reuters) – Eli Lilly & Co may have a $15 billion wild card up its sleeve as it waits for desperately needed new drugs to bear fruit. Should an obscure patent on Lilly lung cancer drug Alimta survive a court challenge this year, the company would be able to wring more than five additional years of peak sales out of the fast-growing product that it would otherwise lose to cheaper generics. Annual sales of Alimta are expected by Wall Street to climb to $3.5 billion by 2016, when its basic patent lapses. …

Ecuador ranked top nation for U.S., Canadian retirees

American tourists are seen at a tree house, which is used to observe Tungurahua volcano activity from 1.2 km (0.75 miles) of the volcano's crater in Banos CityNEW YORK (Reuters) – With its low cost of living, balmy climate and cheap property prices, Ecuador has been ranked the top foreign retirement destination for North Americans for the fifth consecutive year. The South American nation bordered by Colombia and Peru scored the highest marks in InternationalLiving.com's annual ranking of the best places to retire. With monthly estimated living expenses ranging from $900 to $1,400, Ecuador surpassed Panama, Malaysia, Mexico and Costa Rica, which rounded out the top five countries. …

Chavez still has "severe" respiratory problem

Venezuela's Vice President Maduro speaks during a visit to Fama de America's coffee processing plant in CaracasCARACAS (Reuters) – Venezuelan President Hugo Chavez is still suffering a "severe" respiratory infection that has hindered his breathing as he struggles to recover from cancer surgery in Cuba, the government said on Thursday. The 58-year-old socialist leader has not been seen in public nor heard from in more than three weeks. Officials say he is in delicate condition after his fourth operation in just 18 months for an undisclosed form of cancer in his pelvic area. …

1 80 81 82 83 84 92